Jason A. Leverone Reneo Pharmaceuticals, Inc. (RPHM) insider trading activity

Jason A. Leverone is Chief Financial Officer of Reneo Pharmaceuticals, Inc.. Currently has a direct ownership of 16,301 shares of RPHM, which is worth approximately $27,385. The most recent transaction as insider was on Dec 22, 2025, when has been sold 302 shares (Class A Common Stock) at a price of $2.97 per share, resulting in proceeds of $896. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 16.3K

29.34% 3M change

0.18% 12M change

Total Value Held $27,385

Jason A. Leverone Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 22 2025	SELL Open market or private sale	$896 $2.97 p/Share	302 Reduced 1.82%	16,301 Class A Common Stock
Sep 22 2025	SELL Open market or private sale	$793 $2.62 p/Share	303 Reduced 2.35%	12,603 Class A Common Stock
Jun 23 2025	SELL Open market or private sale	$721 $2.38 p/Share	303 Reduced 2.29%	12,906 Class A Common Stock
Apr 07 2025	SELL Open market or private sale	$4,923 $2.67 p/Share	1,844 Reduced 12.25%	13,209 Class A Common Stock
Apr 04 2025	SELL Open market or private sale	$4,255 $3.33 p/Share	1,278 Reduced 7.83%	15,053 Class A Common Stock
Oct 04 2024	BUY Grant, award, or other acquisition	-	16,331 Added 50.0%	16,331 Class A Common Stock

Also insider at

VRDN

Viridian Therapeutics, Inc.\DE Healthcare

Chief Financial Officer

JAL

Jason A. Leverone

Chief Financial Officer

Boulder, CO

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RPHM shares.

Notify only if

Value

Insider Trading

Get notified when an Reneo Pharmaceuticals, Inc. insider buys or sells RPHM shares.

Notify only if

Operation

Value

Type

News

Receive news related to Reneo Pharmaceuticals, Inc.

Track Activities on RPHM

Account